323 related articles for article (PubMed ID: 28887320)
1. p53 gain-of-function mutations increase Cdc7-dependent replication initiation.
Datta A; Ghatak D; Das S; Banerjee T; Paul A; Butti R; Gorain M; Ghuwalewala S; Roychowdhury A; Alam SK; Das P; Chatterjee R; Dasgupta M; Panda CK; Kundu GC; Roychoudhury S
EMBO Rep; 2017 Nov; 18(11):2030-2050. PubMed ID: 28887320
[TBL] [Abstract][Full Text] [Related]
2. DDK Promotes Tumor Chemoresistance and Survival via Multiple Pathways.
Sasi NK; Bhutkar A; Lanning NJ; MacKeigan JP; Weinreich M
Neoplasia; 2017 May; 19(5):439-450. PubMed ID: 28448802
[TBL] [Abstract][Full Text] [Related]
3. Cdc7-dependent and -independent phosphorylation of Claspin in the induction of the DNA replication checkpoint.
Rainey MD; Harhen B; Wang GN; Murphy PV; Santocanale C
Cell Cycle; 2013 May; 12(10):1560-8. PubMed ID: 23598722
[TBL] [Abstract][Full Text] [Related]
4. LKB1 loss by alteration of the NKX2-1/p53 pathway promotes tumor malignancy and predicts poor survival and relapse in lung adenocarcinomas.
Tsai LH; Chen PM; Cheng YW; Chen CY; Sheu GT; Wu TC; Lee H
Oncogene; 2014 Jul; 33(29):3851-60. PubMed ID: 23995788
[TBL] [Abstract][Full Text] [Related]
5. Targeting DNA replication before it starts: Cdc7 as a therapeutic target in p53-mutant breast cancers.
Rodriguez-Acebes S; Proctor I; Loddo M; Wollenschlaeger A; Rashid M; Falzon M; Prevost AT; Sainsbury R; Stoeber K; Williams GH
Am J Pathol; 2010 Oct; 177(4):2034-45. PubMed ID: 20724597
[TBL] [Abstract][Full Text] [Related]
6. Cdc7-Dbf4-mediated phosphorylation of HSP90-S164 stabilizes HSP90-HCLK2-MRN complex to enhance ATR/ATM signaling that overcomes replication stress in cancer.
Cheng AN; Fan CC; Lo YK; Kuo CL; Wang HC; Lien IH; Lin SY; Chen CH; Jiang SS; Chang IS; Juan HF; Lyu PC; Lee AY
Sci Rep; 2017 Dec; 7(1):17024. PubMed ID: 29209046
[TBL] [Abstract][Full Text] [Related]
7. MiR-630 inhibits proliferation by targeting CDC7 kinase, but maintains the apoptotic balance by targeting multiple modulators in human lung cancer A549 cells.
Cao JX; Lu Y; Qi JJ; An GS; Mao ZB; Jia HT; Li SY; Ni JH
Cell Death Dis; 2014 Sep; 5(9):e1426. PubMed ID: 25255219
[TBL] [Abstract][Full Text] [Related]
8. Cdc7 is a potent anti-cancer target in pancreatic cancer due to abrogation of the DNA origin activation checkpoint.
Huggett MT; Tudzarova S; Proctor I; Loddo M; Keane MG; Stoeber K; Williams GH; Pereira SP
Oncotarget; 2016 Apr; 7(14):18495-507. PubMed ID: 26921250
[TBL] [Abstract][Full Text] [Related]
9. The role of the Saccharomyces cerevisiae Cdc7-Dbf4 complex in the replication checkpoint.
Ogi H; Wang CZ; Nakai W; Kawasaki Y; Masumoto H
Gene; 2008 May; 414(1-2):32-40. PubMed ID: 18372119
[TBL] [Abstract][Full Text] [Related]
10. Maturation-associated Dbf4 expression is essential for mouse zygotic DNA replication.
Murai S; Katagiri Y; Yamashita S
Dev Growth Differ; 2014 Dec; 56(9):625-39. PubMed ID: 25348865
[TBL] [Abstract][Full Text] [Related]
11. Essential role of phosphorylation of MCM2 by Cdc7/Dbf4 in the initiation of DNA replication in mammalian cells.
Tsuji T; Ficarro SB; Jiang W
Mol Biol Cell; 2006 Oct; 17(10):4459-72. PubMed ID: 16899510
[TBL] [Abstract][Full Text] [Related]
12. Regulation and roles of Cdc7 kinase under replication stress.
Yamada M; Masai H; Bartek J
Cell Cycle; 2014; 13(12):1859-66. PubMed ID: 24841992
[TBL] [Abstract][Full Text] [Related]
13. Aberrant large tumor suppressor 2 (LATS2) gene expression correlates with EGFR mutation and survival in lung adenocarcinomas.
Luo SY; Sit KY; Sihoe AD; Suen WS; Au WK; Tang X; Ma ES; Chan WK; Wistuba II; Minna JD; Tsao GS; Lam DC
Lung Cancer; 2014 Aug; 85(2):282-92. PubMed ID: 24976335
[TBL] [Abstract][Full Text] [Related]
14. Cdc7-Dbf4 kinase overexpression in multiple cancers and tumor cell lines is correlated with p53 inactivation.
Bonte D; Lindvall C; Liu H; Dykema K; Furge K; Weinreich M
Neoplasia; 2008 Sep; 10(9):920-31. PubMed ID: 18714392
[TBL] [Abstract][Full Text] [Related]
15. Cdc7 inhibition reveals a p53-dependent replication checkpoint that is defective in cancer cells.
Montagnoli A; Tenca P; Sola F; Carpani D; Brotherton D; Albanese C; Santocanale C
Cancer Res; 2004 Oct; 64(19):7110-6. PubMed ID: 15466207
[TBL] [Abstract][Full Text] [Related]
16. p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM.
Song H; Hollstein M; Xu Y
Nat Cell Biol; 2007 May; 9(5):573-80. PubMed ID: 17417627
[TBL] [Abstract][Full Text] [Related]
17. Nuclear PGK1 Alleviates ADP-Dependent Inhibition of CDC7 to Promote DNA Replication.
Li X; Qian X; Jiang H; Xia Y; Zheng Y; Li J; Huang BJ; Fang J; Qian CN; Jiang T; Zeng YX; Lu Z
Mol Cell; 2018 Nov; 72(4):650-660.e8. PubMed ID: 30392930
[TBL] [Abstract][Full Text] [Related]
18. Gain-of-function mutant p53 upregulates CXC chemokines and enhances cell migration.
Yeudall WA; Vaughan CA; Miyazaki H; Ramamoorthy M; Choi MY; Chapman CG; Wang H; Black E; Bulysheva AA; Deb SP; Windle B; Deb S
Carcinogenesis; 2012 Feb; 33(2):442-51. PubMed ID: 22114072
[TBL] [Abstract][Full Text] [Related]
19. Identification of Novel Cdc7 Kinase Inhibitors as Anti-Cancer Agents that Target the Interaction with Dbf4 by the Fragment Complementation and Drug Repositioning Approach.
Cheng AN; Lo YK; Lin YS; Tang TK; Hsu CH; Hsu JT; Lee AY
EBioMedicine; 2018 Oct; 36():241-251. PubMed ID: 30293817
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of cancer cell death induced by depletion of an essential replication regulator.
Ito S; Ishii A; Kakusho N; Taniyama C; Yamazaki S; Fukatsu R; Sakaue-Sawano A; Miyawaki A; Masai H
PLoS One; 2012; 7(5):e36372. PubMed ID: 22574151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
